Lalani, A. A., Pond, G. R., Siva, S., Chu, W., Gopaul, D., Morgan, S. C., Basappa, N. S., Winquist, E., Bonert, M., Bramson, J., Surette, M. G., Azad, A., Spain, L. A., Bjarnason, G. A., Bosse, D., Levine, M. N., Wright, J., Hotte, S. J., Swaminath, A. (2026). CYTOSHRINK: A randomized phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with ipilimumab/nivolumab for metastatic kidney cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.416